Report Overview
Antihyperuricemic agents are also called anti-gout drugs. These drugs correct the overproduction or underexcretion of uric acid.
This report provides a deep insight into the global Antihyperuricemic Agents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antihyperuricemic Agents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antihyperuricemic Agents market in any manner.
Global Antihyperuricemic Agents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda Pharmaceuticals
Hikma
Wockhardt
West Ward Pharmaceuticals
Rhea Pharmaceutical
Medinova
Odan Laboratories
TEIJIN
Casper Pharma
Dr. Reddys Laboratories
Teva
Zydus Pharmaceuticals
Mylan
Sun Pharmaceutical
APOTEX
NorthStar Healthcare
Ipca Laboratories
Accord Healthcare
Gentec Pharmaceutical Group
Indoco Remedies
Lupin
Waterstone Pharmaceuticals
ALP Pharm
Jiangsu Hengrui Medicine
Jiangsu Wanbang Biopharmaceuticals
Hangzhou Zhuyangxin Pharmaceutical
YiChang HEC ChangJiang Pharmaceutical
KPC Pharmaceuticals
Tonghua Limin
Beijing Jialin Pharmaceutical
Market Segmentation (by Type)
Inhibit Uric Acid Production Agents
Promote Uric Acid Excretion Agents
Others
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Antihyperuricemic Agents Market
? Overview of the regional outlook of the Antihyperuricemic Agents Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antihyperuricemic Agents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antihyperuricemic Agents
1.2 Key Market Segments
1.2.1 Antihyperuricemic Agents Segment by Type
1.2.2 Antihyperuricemic Agents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antihyperuricemic Agents Market Overview
2.1 Global Market Overview
2.1.1 Global Antihyperuricemic Agents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antihyperuricemic Agents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antihyperuricemic Agents Market Competitive Landscape
3.1 Global Antihyperuricemic Agents Sales by Manufacturers (2019-2024)
3.2 Global Antihyperuricemic Agents Revenue Market Share by Manufacturers (2019-2024)
3.3 Antihyperuricemic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antihyperuricemic Agents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antihyperuricemic Agents Sales Sites, Area Served, Product Type
3.6 Antihyperuricemic Agents Market Competitive Situation and Trends
3.6.1 Antihyperuricemic Agents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antihyperuricemic Agents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antihyperuricemic Agents Industry Chain Analysis
4.1 Antihyperuricemic Agents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antihyperuricemic Agents Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antihyperuricemic Agents Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antihyperuricemic Agents Sales Market Share by Type (2019-2024)
6.3 Global Antihyperuricemic Agents Market Size Market Share by Type (2019-2024)
6.4 Global Antihyperuricemic Agents Price by Type (2019-2024)
7 Antihyperuricemic Agents Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antihyperuricemic Agents Market Sales by Application (2019-2024)
7.3 Global Antihyperuricemic Agents Market Size (M USD) by Application (2019-2024)
7.4 Global Antihyperuricemic Agents Sales Growth Rate by Application (2019-2024)
8 Antihyperuricemic Agents Market Segmentation by Region
8.1 Global Antihyperuricemic Agents Sales by Region
8.1.1 Global Antihyperuricemic Agents Sales by Region
8.1.2 Global Antihyperuricemic Agents Sales Market Share by Region
8.2 North America
8.2.1 North America Antihyperuricemic Agents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antihyperuricemic Agents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antihyperuricemic Agents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antihyperuricemic Agents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antihyperuricemic Agents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Antihyperuricemic Agents Basic Information
9.1.2 Takeda Pharmaceuticals Antihyperuricemic Agents Product Overview
9.1.3 Takeda Pharmaceuticals Antihyperuricemic Agents Product Market Performance
9.1.4 Takeda Pharmaceuticals Business Overview
9.1.5 Takeda Pharmaceuticals Antihyperuricemic Agents SWOT Analysis
9.1.6 Takeda Pharmaceuticals Recent Developments
9.2 Hikma
9.2.1 Hikma Antihyperuricemic Agents Basic Information
9.2.2 Hikma Antihyperuricemic Agents Product Overview
9.2.3 Hikma Antihyperuricemic Agents Product Market Performance
9.2.4 Hikma Business Overview
9.2.5 Hikma Antihyperuricemic Agents SWOT Analysis
9.2.6 Hikma Recent Developments
9.3 Wockhardt
9.3.1 Wockhardt Antihyperuricemic Agents Basic Information
9.3.2 Wockhardt Antihyperuricemic Agents Product Overview
9.3.3 Wockhardt Antihyperuricemic Agents Product Market Performance
9.3.4 Wockhardt Antihyperuricemic Agents SWOT Analysis
9.3.5 Wockhardt Business Overview
9.3.6 Wockhardt Recent Developments
9.4 West Ward Pharmaceuticals
9.4.1 West Ward Pharmaceuticals Antihyperuricemic Agents Basic Information
9.4.2 West Ward Pharmaceuticals Antihyperuricemic Agents Product Overview
9.4.3 West Ward Pharmaceuticals Antihyperuricemic Agents Product Market Performance
9.4.4 West Ward Pharmaceuticals Business Overview
9.4.5 West Ward Pharmaceuticals Recent Developments
9.5 Rhea Pharmaceutical
9.5.1 Rhea Pharmaceutical Antihyperuricemic Agents Basic Information
9.5.2 Rhea Pharmaceutical Antihyperuricemic Agents Product Overview
9.5.3 Rhea Pharmaceutical Antihyperuricemic Agents Product Market Performance
9.5.4 Rhea Pharmaceutical Business Overview
9.5.5 Rhea Pharmaceutical Recent Developments
9.6 Medinova
9.6.1 Medinova Antihyperuricemic Agents Basic Information
9.6.2 Medinova Antihyperuricemic Agents Product Overview
9.6.3 Medinova Antihyperuricemic Agents Product Market Performance
9.6.4 Medinova Business Overview
9.6.5 Medinova Recent Developments
9.7 Odan Laboratories
9.7.1 Odan Laboratories Antihyperuricemic Agents Basic Information
9.7.2 Odan Laboratories Antihyperuricemic Agents Product Overview
9.7.3 Odan Laboratories Antihyperuricemic Agents Product Market Performance
9.7.4 Odan Laboratories Business Overview
9.7.5 Odan Laboratories Recent Developments
9.8 TEIJIN
9.8.1 TEIJIN Antihyperuricemic Agents Basic Information
9.8.2 TEIJIN Antihyperuricemic Agents Product Overview
9.8.3 TEIJIN Antihyperuricemic Agents Product Market Performance
9.8.4 TEIJIN Business Overview
9.8.5 TEIJIN Recent Developments
9.9 Casper Pharma
9.9.1 Casper Pharma Antihyperuricemic Agents Basic Information
9.9.2 Casper Pharma Antihyperuricemic Agents Product Overview
9.9.3 Casper Pharma Antihyperuricemic Agents Product Market Performance
9.9.4 Casper Pharma Business Overview
9.9.5 Casper Pharma Recent Developments
9.10 Dr. Reddys Laboratories
9.10.1 Dr. Reddys Laboratories Antihyperuricemic Agents Basic Information
9.10.2 Dr. Reddys Laboratories Antihyperuricemic Agents Product Overview
9.10.3 Dr. Reddys Laboratories Antihyperuricemic Agents Product Market Performance
9.10.4 Dr. Reddys Laboratories Business Overview
9.10.5 Dr. Reddys Laboratories Recent Developments
9.11 Teva
9.11.1 Teva Antihyperuricemic Agents Basic Information
9.11.2 Teva Antihyperuricemic Agents Product Overview
9.11.3 Teva Antihyperuricemic Agents Product Market Performance
9.11.4 Teva Business Overview
9.11.5 Teva Recent Developments
9.12 Zydus Pharmaceuticals
9.12.1 Zydus Pharmaceuticals Antihyperuricemic Agents Basic Information
9.12.2 Zydus Pharmaceuticals Antihyperuricemic Agents Product Overview
9.12.3 Zydus Pharmaceuticals Antihyperuricemic Agents Product Market Performance
9.12.4 Zydus Pharmaceuticals Business Overview
9.12.5 Zydus Pharmaceuticals Recent Developments
9.13 Mylan
9.13.1 Mylan Antihyperuricemic Agents Basic Information
9.13.2 Mylan Antihyperuricemic Agents Product Overview
9.13.3 Mylan Antihyperuricemic Agents Product Market Performance
9.13.4 Mylan Business Overview
9.13.5 Mylan Recent Developments
9.14 Sun Pharmaceutical
9.14.1 Sun Pharmaceutical Antihyperuricemic Agents Basic Information
9.14.2 Sun Pharmaceutical Antihyperuricemic Agents Product Overview
9.14.3 Sun Pharmaceutical Antihyperuricemic Agents Product Market Performance
9.14.4 Sun Pharmaceutical Business Overview
9.14.5 Sun Pharmaceutical Recent Developments
9.15 APOTEX
9.15.1 APOTEX Antihyperuricemic Agents Basic Information
9.15.2 APOTEX Antihyperuricemic Agents Product Overview
9.15.3 APOTEX Antihyperuricemic Agents Product Market Performance
9.15.4 APOTEX Business Overview
9.15.5 APOTEX Recent Developments
9.16 NorthStar Healthcare
9.16.1 NorthStar Healthcare Antihyperuricemic Agents Basic Information
9.16.2 NorthStar Healthcare Antihyperuricemic Agents Product Overview
9.16.3 NorthStar Healthcare Antihyperuricemic Agents Product Market Performance
9.16.4 NorthStar Healthcare Business Overview
9.16.5 NorthStar Healthcare Recent Developments
9.17 Ipca Laboratories
9.17.1 Ipca Laboratories Antihyperuricemic Agents Basic Information
9.17.2 Ipca Laboratories Antihyperuricemic Agents Product Overview
9.17.3 Ipca Laboratories Antihyperuricemic Agents Product Market Performance
9.17.4 Ipca Laboratories Business Overview
9.17.5 Ipca Laboratories Recent Developments
9.18 Accord Healthcare
9.18.1 Accord Healthcare Antihyperuricemic Agents Basic Information
9.18.2 Accord Healthcare Antihyperuricemic Agents Product Overview
9.18.3 Accord Healthcare Antihyperuricemic Agents Product Market Performance
9.18.4 Accord Healthcare Business Overview
9.18.5 Accord Healthcare Recent Developments
9.19 Gentec Pharmaceutical Group
9.19.1 Gentec Pharmaceutical Group Antihyperuricemic Agents Basic Information
9.19.2 Gentec Pharmaceutical Group Antihyperuricemic Agents Product Overview
9.19.3 Gentec Pharmaceutical Group Antihyperuricemic Agents Product Market Performance
9.19.4 Gentec Pharmaceutical Group Business Overview
9.19.5 Gentec Pharmaceutical Group Recent Developments
9.20 Indoco Remedies
9.20.1 Indoco Remedies Antihyperuricemic Agents Basic Information
9.20.2 Indoco Remedies Antihyperuricemic Agents Product Overview
9.20.3 Indoco Remedies Antihyperuricemic Agents Product Market Performance
9.20.4 Indoco Remedies Business Overview
9.20.5 Indoco Remedies Recent Developments
9.21 Lupin
9.21.1 Lupin Antihyperuricemic Agents Basic Information
9.21.2 Lupin Antihyperuricemic Agents Product Overview
9.21.3 Lupin Antihyperuricemic Agents Product Market Performance
9.21.4 Lupin Business Overview
9.21.5 Lupin Recent Developments
9.22 Waterstone Pharmaceuticals
9.22.1 Waterstone Pharmaceuticals Antihyperuricemic Agents Basic Information
9.22.2 Waterstone Pharmaceuticals Antihyperuricemic Agents Product Overview
9.22.3 Waterstone Pharmaceuticals Antihyperuricemic Agents Product Market Performance
9.22.4 Waterstone Pharmaceuticals Business Overview
9.22.5 Waterstone Pharmaceuticals Recent Developments
9.23 ALP Pharm
9.23.1 ALP Pharm Antihyperuricemic Agents Basic Information
9.23.2 ALP Pharm Antihyperuricemic Agents Product Overview
9.23.3 ALP Pharm Antihyperuricemic Agents Product Market Performance
9.23.4 ALP Pharm Business Overview
9.23.5 ALP Pharm Recent Developments
9.24 Jiangsu Hengrui Medicine
9.24.1 Jiangsu Hengrui Medicine Antihyperuricemic Agents Basic Information
9.24.2 Jiangsu Hengrui Medicine Antihyperuricemic Agents Product Overview
9.24.3 Jiangsu Hengrui Medicine Antihyperuricemic Agents Product Market Performance
9.24.4 Jiangsu Hengrui Medicine Business Overview
9.24.5 Jiangsu Hengrui Medicine Recent Developments
9.25 Jiangsu Wanbang Biopharmaceuticals
9.25.1 Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Basic Information
9.25.2 Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Product Overview
9.25.3 Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Product Market Performance
9.25.4 Jiangsu Wanbang Biopharmaceuticals Business Overview
9.25.5 Jiangsu Wanbang Biopharmaceuticals Recent Developments
9.26 Hangzhou Zhuyangxin Pharmaceutical
9.26.1 Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Basic Information
9.26.2 Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Product Overview
9.26.3 Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Product Market Performance
9.26.4 Hangzhou Zhuyangxin Pharmaceutical Business Overview
9.26.5 Hangzhou Zhuyangxin Pharmaceutical Recent Developments
9.27 YiChang HEC ChangJiang Pharmaceutical
9.27.1 YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Basic Information
9.27.2 YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Product Overview
9.27.3 YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Product Market Performance
9.27.4 YiChang HEC ChangJiang Pharmaceutical Business Overview
9.27.5 YiChang HEC ChangJiang Pharmaceutical Recent Developments
9.28 KPC Pharmaceuticals
9.28.1 KPC Pharmaceuticals Antihyperuricemic Agents Basic Information
9.28.2 KPC Pharmaceuticals Antihyperuricemic Agents Product Overview
9.28.3 KPC Pharmaceuticals Antihyperuricemic Agents Product Market Performance
9.28.4 KPC Pharmaceuticals Business Overview
9.28.5 KPC Pharmaceuticals Recent Developments
9.29 Tonghua Limin
9.29.1 Tonghua Limin Antihyperuricemic Agents Basic Information
9.29.2 Tonghua Limin Antihyperuricemic Agents Product Overview
9.29.3 Tonghua Limin Antihyperuricemic Agents Product Market Performance
9.29.4 Tonghua Limin Business Overview
9.29.5 Tonghua Limin Recent Developments
9.30 Beijing Jialin Pharmaceutical
9.30.1 Beijing Jialin Pharmaceutical Antihyperuricemic Agents Basic Information
9.30.2 Beijing Jialin Pharmaceutical Antihyperuricemic Agents Product Overview
9.30.3 Beijing Jialin Pharmaceutical Antihyperuricemic Agents Product Market Performance
9.30.4 Beijing Jialin Pharmaceutical Business Overview
9.30.5 Beijing Jialin Pharmaceutical Recent Developments
10 Antihyperuricemic Agents Market Forecast by Region
10.1 Global Antihyperuricemic Agents Market Size Forecast
10.2 Global Antihyperuricemic Agents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antihyperuricemic Agents Market Size Forecast by Country
10.2.3 Asia Pacific Antihyperuricemic Agents Market Size Forecast by Region
10.2.4 South America Antihyperuricemic Agents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antihyperuricemic Agents by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Antihyperuricemic Agents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antihyperuricemic Agents by Type (2025-2030)
11.1.2 Global Antihyperuricemic Agents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antihyperuricemic Agents by Type (2025-2030)
11.2 Global Antihyperuricemic Agents Market Forecast by Application (2025-2030)
11.2.1 Global Antihyperuricemic Agents Sales (Kilotons) Forecast by Application
11.2.2 Global Antihyperuricemic Agents Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antihyperuricemic Agents Market Size Comparison by Region (M USD)
Table 5. Global Antihyperuricemic Agents Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antihyperuricemic Agents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antihyperuricemic Agents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antihyperuricemic Agents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihyperuricemic Agents as of 2022)
Table 10. Global Market Antihyperuricemic Agents Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antihyperuricemic Agents Sales Sites and Area Served
Table 12. Manufacturers Antihyperuricemic Agents Product Type
Table 13. Global Antihyperuricemic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antihyperuricemic Agents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antihyperuricemic Agents Market Challenges
Table 22. Global Antihyperuricemic Agents Sales by Type (Kilotons)
Table 23. Global Antihyperuricemic Agents Market Size by Type (M USD)
Table 24. Global Antihyperuricemic Agents Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antihyperuricemic Agents Sales Market Share by Type (2019-2024)
Table 26. Global Antihyperuricemic Agents Market Size (M USD) by Type (2019-2024)
Table 27. Global Antihyperuricemic Agents Market Size Share by Type (2019-2024)
Table 28. Global Antihyperuricemic Agents Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antihyperuricemic Agents Sales (Kilotons) by Application
Table 30. Global Antihyperuricemic Agents Market Size by Application
Table 31. Global Antihyperuricemic Agents Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antihyperuricemic Agents Sales Market Share by Application (2019-2024)
Table 33. Global Antihyperuricemic Agents Sales by Application (2019-2024) & (M USD)
Table 34. Global Antihyperuricemic Agents Market Share by Application (2019-2024)
Table 35. Global Antihyperuricemic Agents Sales Growth Rate by Application (2019-2024)
Table 36. Global Antihyperuricemic Agents Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antihyperuricemic Agents Sales Market Share by Region (2019-2024)
Table 38. North America Antihyperuricemic Agents Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antihyperuricemic Agents Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antihyperuricemic Agents Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antihyperuricemic Agents Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antihyperuricemic Agents Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Pharmaceuticals Antihyperuricemic Agents Basic Information
Table 44. Takeda Pharmaceuticals Antihyperuricemic Agents Product Overview
Table 45. Takeda Pharmaceuticals Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Pharmaceuticals Business Overview
Table 47. Takeda Pharmaceuticals Antihyperuricemic Agents SWOT Analysis
Table 48. Takeda Pharmaceuticals Recent Developments
Table 49. Hikma Antihyperuricemic Agents Basic Information
Table 50. Hikma Antihyperuricemic Agents Product Overview
Table 51. Hikma Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Hikma Business Overview
Table 53. Hikma Antihyperuricemic Agents SWOT Analysis
Table 54. Hikma Recent Developments
Table 55. Wockhardt Antihyperuricemic Agents Basic Information
Table 56. Wockhardt Antihyperuricemic Agents Product Overview
Table 57. Wockhardt Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Wockhardt Antihyperuricemic Agents SWOT Analysis
Table 59. Wockhardt Business Overview
Table 60. Wockhardt Recent Developments
Table 61. West Ward Pharmaceuticals Antihyperuricemic Agents Basic Information
Table 62. West Ward Pharmaceuticals Antihyperuricemic Agents Product Overview
Table 63. West Ward Pharmaceuticals Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. West Ward Pharmaceuticals Business Overview
Table 65. West Ward Pharmaceuticals Recent Developments
Table 66. Rhea Pharmaceutical Antihyperuricemic Agents Basic Information
Table 67. Rhea Pharmaceutical Antihyperuricemic Agents Product Overview
Table 68. Rhea Pharmaceutical Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Rhea Pharmaceutical Business Overview
Table 70. Rhea Pharmaceutical Recent Developments
Table 71. Medinova Antihyperuricemic Agents Basic Information
Table 72. Medinova Antihyperuricemic Agents Product Overview
Table 73. Medinova Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Medinova Business Overview
Table 75. Medinova Recent Developments
Table 76. Odan Laboratories Antihyperuricemic Agents Basic Information
Table 77. Odan Laboratories Antihyperuricemic Agents Product Overview
Table 78. Odan Laboratories Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Odan Laboratories Business Overview
Table 80. Odan Laboratories Recent Developments
Table 81. TEIJIN Antihyperuricemic Agents Basic Information
Table 82. TEIJIN Antihyperuricemic Agents Product Overview
Table 83. TEIJIN Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. TEIJIN Business Overview
Table 85. TEIJIN Recent Developments
Table 86. Casper Pharma Antihyperuricemic Agents Basic Information
Table 87. Casper Pharma Antihyperuricemic Agents Product Overview
Table 88. Casper Pharma Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Casper Pharma Business Overview
Table 90. Casper Pharma Recent Developments
Table 91. Dr. Reddys Laboratories Antihyperuricemic Agents Basic Information
Table 92. Dr. Reddys Laboratories Antihyperuricemic Agents Product Overview
Table 93. Dr. Reddys Laboratories Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Dr. Reddys Laboratories Business Overview
Table 95. Dr. Reddys Laboratories Recent Developments
Table 96. Teva Antihyperuricemic Agents Basic Information
Table 97. Teva Antihyperuricemic Agents Product Overview
Table 98. Teva Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Teva Business Overview
Table 100. Teva Recent Developments
Table 101. Zydus Pharmaceuticals Antihyperuricemic Agents Basic Information
Table 102. Zydus Pharmaceuticals Antihyperuricemic Agents Product Overview
Table 103. Zydus Pharmaceuticals Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zydus Pharmaceuticals Business Overview
Table 105. Zydus Pharmaceuticals Recent Developments
Table 106. Mylan Antihyperuricemic Agents Basic Information
Table 107. Mylan Antihyperuricemic Agents Product Overview
Table 108. Mylan Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Mylan Business Overview
Table 110. Mylan Recent Developments
Table 111. Sun Pharmaceutical Antihyperuricemic Agents Basic Information
Table 112. Sun Pharmaceutical Antihyperuricemic Agents Product Overview
Table 113. Sun Pharmaceutical Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Sun Pharmaceutical Business Overview
Table 115. Sun Pharmaceutical Recent Developments
Table 116. APOTEX Antihyperuricemic Agents Basic Information
Table 117. APOTEX Antihyperuricemic Agents Product Overview
Table 118. APOTEX Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. APOTEX Business Overview
Table 120. APOTEX Recent Developments
Table 121. NorthStar Healthcare Antihyperuricemic Agents Basic Information
Table 122. NorthStar Healthcare Antihyperuricemic Agents Product Overview
Table 123. NorthStar Healthcare Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. NorthStar Healthcare Business Overview
Table 125. NorthStar Healthcare Recent Developments
Table 126. Ipca Laboratories Antihyperuricemic Agents Basic Information
Table 127. Ipca Laboratories Antihyperuricemic Agents Product Overview
Table 128. Ipca Laboratories Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Ipca Laboratories Business Overview
Table 130. Ipca Laboratories Recent Developments
Table 131. Accord Healthcare Antihyperuricemic Agents Basic Information
Table 132. Accord Healthcare Antihyperuricemic Agents Product Overview
Table 133. Accord Healthcare Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Accord Healthcare Business Overview
Table 135. Accord Healthcare Recent Developments
Table 136. Gentec Pharmaceutical Group Antihyperuricemic Agents Basic Information
Table 137. Gentec Pharmaceutical Group Antihyperuricemic Agents Product Overview
Table 138. Gentec Pharmaceutical Group Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Gentec Pharmaceutical Group Business Overview
Table 140. Gentec Pharmaceutical Group Recent Developments
Table 141. Indoco Remedies Antihyperuricemic Agents Basic Information
Table 142. Indoco Remedies Antihyperuricemic Agents Product Overview
Table 143. Indoco Remedies Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Indoco Remedies Business Overview
Table 145. Indoco Remedies Recent Developments
Table 146. Lupin Antihyperuricemic Agents Basic Information
Table 147. Lupin Antihyperuricemic Agents Product Overview
Table 148. Lupin Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Lupin Business Overview
Table 150. Lupin Recent Developments
Table 151. Waterstone Pharmaceuticals Antihyperuricemic Agents Basic Information
Table 152. Waterstone Pharmaceuticals Antihyperuricemic Agents Product Overview
Table 153. Waterstone Pharmaceuticals Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Waterstone Pharmaceuticals Business Overview
Table 155. Waterstone Pharmaceuticals Recent Developments
Table 156. ALP Pharm Antihyperuricemic Agents Basic Information
Table 157. ALP Pharm Antihyperuricemic Agents Product Overview
Table 158. ALP Pharm Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. ALP Pharm Business Overview
Table 160. ALP Pharm Recent Developments
Table 161. Jiangsu Hengrui Medicine Antihyperuricemic Agents Basic Information
Table 162. Jiangsu Hengrui Medicine Antihyperuricemic Agents Product Overview
Table 163. Jiangsu Hengrui Medicine Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 164. Jiangsu Hengrui Medicine Business Overview
Table 165. Jiangsu Hengrui Medicine Recent Developments
Table 166. Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Basic Information
Table 167. Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Product Overview
Table 168. Jiangsu Wanbang Biopharmaceuticals Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 169. Jiangsu Wanbang Biopharmaceuticals Business Overview
Table 170. Jiangsu Wanbang Biopharmaceuticals Recent Developments
Table 171. Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Basic Information
Table 172. Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Product Overview
Table 173. Hangzhou Zhuyangxin Pharmaceutical Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 174. Hangzhou Zhuyangxin Pharmaceutical Business Overview
Table 175. Hangzhou Zhuyangxin Pharmaceutical Recent Developments
Table 176. YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Basic Information
Table 177. YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Product Overview
Table 178. YiChang HEC ChangJiang Pharmaceutical Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 179. YiChang HEC ChangJiang Pharmaceutical Business Overview
Table 180. YiChang HEC ChangJiang Pharmaceutical Recent Developments
Table 181. KPC Pharmaceuticals Antihyperuricemic Agents Basic Information
Table 182. KPC Pharmaceuticals Antihyperuricemic Agents Product Overview
Table 183. KPC Pharmaceuticals Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 184. KPC Pharmaceuticals Business Overview
Table 185. KPC Pharmaceuticals Recent Developments
Table 186. Tonghua Limin Antihyperuricemic Agents Basic Information
Table 187. Tonghua Limin Antihyperuricemic Agents Product Overview
Table 188. Tonghua Limin Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 189. Tonghua Limin Business Overview
Table 190. Tonghua Limin Recent Developments
Table 191. Beijing Jialin Pharmaceutical Antihyperuricemic Agents Basic Information
Table 192. Beijing Jialin Pharmaceutical Antihyperuricemic Agents Product Overview
Table 193. Beijing Jialin Pharmaceutical Antihyperuricemic Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 194. Beijing Jialin Pharmaceutical Business Overview
Table 195. Beijing Jialin Pharmaceutical Recent Developments
Table 196. Global Antihyperuricemic Agents Sales Forecast by Region (2025-2030) & (Kilotons)
Table 197. Global Antihyperuricemic Agents Market Size Forecast by Region (2025-2030) & (M USD)
Table 198. North America Antihyperuricemic Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 199. North America Antihyperuricemic Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 200. Europe Antihyperuricemic Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 201. Europe Antihyperuricemic Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 202. Asia Pacific Antihyperuricemic Agents Sales Forecast by Region (2025-2030) & (Kilotons)
Table 203. Asia Pacific Antihyperuricemic Agents Market Size Forecast by Region (2025-2030) & (M USD)
Table 204. South America Antihyperuricemic Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 205. South America Antihyperuricemic Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 206. Middle East and Africa Antihyperuricemic Agents Consumption Forecast by Country (2025-2030) & (Units)
Table 207. Middle East and Africa Antihyperuricemic Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 208. Global Antihyperuricemic Agents Sales Forecast by Type (2025-2030) & (Kilotons)
Table 209. Global Antihyperuricemic Agents Market Size Forecast by Type (2025-2030) & (M USD)
Table 210. Global Antihyperuricemic Agents Price Forecast by Type (2025-2030) & (USD/Ton)
Table 211. Global Antihyperuricemic Agents Sales (Kilotons) Forecast by Application (2025-2030)
Table 212. Global Antihyperuricemic Agents Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Antihyperuricemic Agents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antihyperuricemic Agents Market Size (M USD), 2019-2030
Figure 5. Global Antihyperuricemic Agents Market Size (M USD) (2019-2030)
Figure 6. Global Antihyperuricemic Agents Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antihyperuricemic Agents Market Size by Country (M USD)
Figure 11. Antihyperuricemic Agents Sales Share by Manufacturers in 2023
Figure 12. Global Antihyperuricemic Agents Revenue Share by Manufacturers in 2023
Figure 13. Antihyperuricemic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antihyperuricemic Agents Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antihyperuricemic Agents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antihyperuricemic Agents Market Share by Type
Figure 18. Sales Market Share of Antihyperuricemic Agents by Type (2019-2024)
Figure 19. Sales Market Share of Antihyperuricemic Agents by Type in 2023
Figure 20. Market Size Share of Antihyperuricemic Agents by Type (2019-2024)
Figure 21. Market Size Market Share of Antihyperuricemic Agents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antihyperuricemic Agents Market Share by Application
Figure 24. Global Antihyperuricemic Agents Sales Market Share by Application (2019-2024)
Figure 25. Global Antihyperuricemic Agents Sales Market Share by Application in 2023
Figure 26. Global Antihyperuricemic Agents Market Share by Application (2019-2024)
Figure 27. Global Antihyperuricemic Agents Market Share by Application in 2023
Figure 28. Global Antihyperuricemic Agents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antihyperuricemic Agents Sales Market Share by Region (2019-2024)
Figure 30. North America Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antihyperuricemic Agents Sales Market Share by Country in 2023
Figure 32. U.S. Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antihyperuricemic Agents Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antihyperuricemic Agents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antihyperuricemic Agents Sales Market Share by Country in 2023
Figure 37. Germany Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antihyperuricemic Agents Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antihyperuricemic Agents Sales Market Share by Region in 2023
Figure 44. China Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antihyperuricemic Agents Sales and Growth Rate (Kilotons)
Figure 50. South America Antihyperuricemic Agents Sales Market Share by Country in 2023
Figure 51. Brazil Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antihyperuricemic Agents Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antihyperuricemic Agents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antihyperuricemic Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antihyperuricemic Agents Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antihyperuricemic Agents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antihyperuricemic Agents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antihyperuricemic Agents Market Share Forecast by Type (2025-2030)
Figure 65. Global Antihyperuricemic Agents Sales Forecast by Application (2025-2030)
Figure 66. Global Antihyperuricemic Agents Market Share Forecast by Application (2025-2030)
